@article{b4296ec519394636b47d30273cf913f9,
title = "Letter: tofacitinib use for biologic-refractory paediatric inflammatory bowel disease",
author = "Dolinger, \{Michael T.\} and Priya Rolfes and Phan, \{Becky L.\} and Dubinsky, \{Marla C.\}",
note = "Funding Information: We thank John {\textquoteleft}Jack{\textquoteright} Rowland for his mentorship and guidance during data collection and statistical analysis. Declaration of personal interests: Dr Marla C. Dubinsky is a consultant for Pfizer, Janssen, Takeda, and AbbVie, and receives research support from Pfizer Inc.",
year = "2019",
month = oct,
day = "1",
doi = "10.1111/apt.15496",
language = "English",
volume = "50",
pages = "966--967",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "John Wiley and Sons Inc.",
number = "8",
}